RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY

SCOPUS
  • Year: 2021
  • Volume: 14
  • Issue: 2

The GC MS study of one Ayurvedic formulation “Sitopaladi”

  • Author:
  • D Sharmila1, A Poovarasan2, E Pradeep2, Tanmoy Saha2, Mudiganti Ram Krishna Rao3*, K Prabhu4
  • Total Page Count: 5
  • Page Number: 911 to 915

1Assit. Professor, Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai

2Student, Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai

3Professor, Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai.

4Associate Professor, Department of Anatomy, Sree Balaji Medical College and Hospital, Chrompet, Chennai.

*Corresponding Author E-mail: mrkrao1455@gmail.com

Online published on 30 April, 2021.

Abstract

The present study deals with the GC MS analysis of one Ayurvedic emedicine, Sitopaladi, which is prescribed for the treatment of respiratory diseases. Sitopaldai was purchased for standard Ayurvedic vendor at Chennai and subjected to GC MS analysis following standard protocol. Some biomolecules of medicinal importance such as Clindamycin, d-Glycero-d-ido-heptose, Agaricic acid, n-Hexadecanoic acid, cis-13-Octadecenoic acid, Oleic Acid. Hexadecanoic acid, 1-(hydroxymethyl)-1, 2-ethanediyl, 4-Fluorobenzoic acid, 1-adamantylmethyl ester, 2 ’, 3′-O-p-Anisylideneguanosine, 8, 14-Seco-3, 19-epoxyandrostane-8, 14-dione, 17-acetoxy-3.beta.-methoxy-4, 4-dimethyl-, 8-(2, 5-Dimethoxyphenyl)-6-methyl-2-(4-methylpent-3-enyl)octa-2, 6-dienoic acid, ethyl ester were indicated in the in GCMS profile, which have roles similar to that of Sitopaladi.

Keywords

GC MS, Sitopaladi, Clindamycin, D-Glycero-d-ido-heptose, Agaricic acid, N-Hexadecanoic acid, Cis-13-Octadecenoic acid, Oleic Acid, Hexadecanoic acid, 1-(hydroxymethyl)-1, 2-ethanediyl, 4-Fluorobenzoic acid, 1-adamantylmethyl ester